Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310207265> ?p ?o ?g. }
- W4310207265 endingPage "667" @default.
- W4310207265 startingPage "659" @default.
- W4310207265 abstract "The inwardly rectifying potassium current of the cardiomyocyte (IK1) is the main determinant of the resting potential. Ion channels Kir2.1, Kir2.2, and Kir2.3 form tetramers and are the molecular correlate of macroscopic IK1 current. Verapamil is an antiarrhythmic drug used to suppress atrial and ventricular arrhythmias. Its primary mechanism of action is via blocking calcium channels. In addition, it has been demonstrated to block IK1 current and the Kir2.1 subunit. Its effect on other subunits that contribute to IK1 current has not been studied to date. We therefore analyzed the effect of verapamil on the Kir channels 2.1, 2.2, and 2.3 in the Xenopus oocyte expression system. Kir2.1, Kir2.2, and Kir2.3 channels were heterologously expressed in Xenopus oocytes. Respective currents were measured with the voltage clamp technique and the effect of verapamil on the current was measured. At a concentration of 300 µM, verapamil inhibited Kir2.1 channels by 41.36% ± 2.7 of the initial current, Kir2.2 channels by 16.51 ± 3.6%, and Kir2.3 by 69.98 ± 4.2%. As a verapamil effect on kir2.3 was a previously unknown finding, we analyzed this effect further. At wash in with 300 µM verapamil, the maximal effect was seen within 20 min of the infusion. After washing out with control solution, there was only a partial current recovery. The current reduction from verapamil was the same at - 120 mV (73.2 ± 3.7%), - 40 mV (85.5 ± 6.5%), and 0 mV (61.5 ± 10.6%) implying no voltage dependency of the block. Using site directed mutations in putative binding sites, we demonstrated a decrease of effect with pore mutant E291A and absence of verapamil effect for D251A. With mutant I214L, which shows a stronger affinity for PIP2 binding, we observed a normalized current reduction to 61.9 ± 0.06% of the control current, which was significantly less pronounced compared to wild type channels. Verapamil blocks Kir2.1, Kir2.2, and Kir2.3 subunits. In Kir2.3, blockade is dependent on sites E291 and D251 and interferes with activation of the channel via PIP2. Interference with these sites and with PIP2 binding has also been described for other Kir channels blocking drugs. As Kir2.3 is preferentially expressed in atrium, a selective Kir2.3 blocking agent would constitute an interesting antiarrhythmic concept." @default.
- W4310207265 created "2022-11-30" @default.
- W4310207265 creator A5006403228 @default.
- W4310207265 creator A5008704300 @default.
- W4310207265 creator A5009280271 @default.
- W4310207265 creator A5028986615 @default.
- W4310207265 creator A5041675024 @default.
- W4310207265 creator A5045785799 @default.
- W4310207265 creator A5049262839 @default.
- W4310207265 creator A5061246638 @default.
- W4310207265 creator A5087346522 @default.
- W4310207265 date "2022-11-29" @default.
- W4310207265 modified "2023-10-14" @default.
- W4310207265 title "Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP2 binding" @default.
- W4310207265 cites W1525108033 @default.
- W4310207265 cites W1587470262 @default.
- W4310207265 cites W182402001 @default.
- W4310207265 cites W1922612499 @default.
- W4310207265 cites W1966321381 @default.
- W4310207265 cites W1967159537 @default.
- W4310207265 cites W1972259953 @default.
- W4310207265 cites W1984984289 @default.
- W4310207265 cites W1985385907 @default.
- W4310207265 cites W1986414724 @default.
- W4310207265 cites W1989035280 @default.
- W4310207265 cites W2005269777 @default.
- W4310207265 cites W2014743555 @default.
- W4310207265 cites W2015183532 @default.
- W4310207265 cites W2016555254 @default.
- W4310207265 cites W2017818826 @default.
- W4310207265 cites W2025955982 @default.
- W4310207265 cites W2032138405 @default.
- W4310207265 cites W2053884799 @default.
- W4310207265 cites W2054024524 @default.
- W4310207265 cites W2068662314 @default.
- W4310207265 cites W2078183328 @default.
- W4310207265 cites W2082510854 @default.
- W4310207265 cites W2084265884 @default.
- W4310207265 cites W2088024909 @default.
- W4310207265 cites W2089588941 @default.
- W4310207265 cites W2100078256 @default.
- W4310207265 cites W2112433596 @default.
- W4310207265 cites W2114512633 @default.
- W4310207265 cites W2125518902 @default.
- W4310207265 cites W2126627460 @default.
- W4310207265 cites W2130198531 @default.
- W4310207265 cites W2131584867 @default.
- W4310207265 cites W2138364054 @default.
- W4310207265 cites W2148571014 @default.
- W4310207265 cites W2150629896 @default.
- W4310207265 cites W2154122229 @default.
- W4310207265 cites W2157698700 @default.
- W4310207265 cites W2161227647 @default.
- W4310207265 cites W2162460172 @default.
- W4310207265 cites W2165564780 @default.
- W4310207265 cites W2168083354 @default.
- W4310207265 cites W2317197323 @default.
- W4310207265 cites W2509795914 @default.
- W4310207265 cites W2586811096 @default.
- W4310207265 cites W2904689287 @default.
- W4310207265 cites W3004050106 @default.
- W4310207265 doi "https://doi.org/10.1007/s00210-022-02342-z" @default.
- W4310207265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36445385" @default.
- W4310207265 hasPublicationYear "2022" @default.
- W4310207265 type Work @default.
- W4310207265 citedByCount "0" @default.
- W4310207265 crossrefType "journal-article" @default.
- W4310207265 hasAuthorship W4310207265A5006403228 @default.
- W4310207265 hasAuthorship W4310207265A5008704300 @default.
- W4310207265 hasAuthorship W4310207265A5009280271 @default.
- W4310207265 hasAuthorship W4310207265A5028986615 @default.
- W4310207265 hasAuthorship W4310207265A5041675024 @default.
- W4310207265 hasAuthorship W4310207265A5045785799 @default.
- W4310207265 hasAuthorship W4310207265A5049262839 @default.
- W4310207265 hasAuthorship W4310207265A5061246638 @default.
- W4310207265 hasAuthorship W4310207265A5087346522 @default.
- W4310207265 hasBestOaLocation W43102072651 @default.
- W4310207265 hasConcept C104317684 @default.
- W4310207265 hasConcept C12554922 @default.
- W4310207265 hasConcept C147944092 @default.
- W4310207265 hasConcept C170493617 @default.
- W4310207265 hasConcept C178790620 @default.
- W4310207265 hasConcept C185592680 @default.
- W4310207265 hasConcept C2777022698 @default.
- W4310207265 hasConcept C2779535977 @default.
- W4310207265 hasConcept C50254741 @default.
- W4310207265 hasConcept C519063684 @default.
- W4310207265 hasConcept C55493867 @default.
- W4310207265 hasConcept C83743174 @default.
- W4310207265 hasConcept C86803240 @default.
- W4310207265 hasConcept C94924445 @default.
- W4310207265 hasConcept C98274493 @default.
- W4310207265 hasConceptScore W4310207265C104317684 @default.
- W4310207265 hasConceptScore W4310207265C12554922 @default.
- W4310207265 hasConceptScore W4310207265C147944092 @default.
- W4310207265 hasConceptScore W4310207265C170493617 @default.
- W4310207265 hasConceptScore W4310207265C178790620 @default.
- W4310207265 hasConceptScore W4310207265C185592680 @default.